Literature DB >> 940279

Skeletal resistance to the calcemic action of parathyroid hormone in uremia: role of 1,25 (OH)2 D3.

S G Massry, R Stein, J Garty, A I Arieff, J W Coburn, A W Norman, R M Friedler.   

Abstract

Studies were carried out to investigate the role of 1,25(OH)2D3 in the skeletal resistance to the calcemic action of parathyroid hormone. The change in serum calcium after the intravenous infusion of 2 U of parathyroid extract (PTE)/kg body wt/hr for eight hours was evaluated in thyroparathyroidectomized (T-PTX) dogs before, and one, two and three days after, induction of uremia by bilateral ureteral ligation (11 dogs) or by bilateral nephrectomy (8 dogs). In another six nephrectomized and T-PTX dogs, 0.68 ug of 1, 25 (OH)2D3/day was given on the day of nephrectomy and for two days thereafter. Serum creatinine in each day of the study was not different among the three groups. The study also included the evaluation of the effect of sham operation (five dogs) and the administration of 1,25 (OH)2D3 to dogs with normal renal function (four dogs) on the calcemic response to PTE, as well as the reproducibility of such a response in the same animal. The results showed that 1) the calcemic response to PTE was markedly impaired after one day of bilateral ureteral ligation or nephrectomy, but the impairment was more severe after nephrectomy; 2) the calcemic response to PTE after two or three days of bilateral ureteral ligation was similar to that seen at one day after nephrectomy; 3) 1, 25 (OH)2D3 partially restored the calcemic response to PTE in the nephrectomized animals to levels similar to those seen after one day of bilateral ureteral ligation; 4) sham operation did not affect the response to PTE, and repeated infusion of PTE produced similar changes in the concentrations of serum calcium. The data indicate that (a) a deficiency of 1,25 (OH)2D3 is at least partly responsible for the skeletal resistance to the calcemic action of PTH in uremia; (b) uremia, per se, may also contribute to this phenomenon; and (c) the kidney after one day of complete bilateral ureteral ligation may still produce 1,25 (OH)2D3, but this ability is compromised after two days of ureteral obstruction.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 940279     DOI: 10.1038/ki.1976.60

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  18 in total

Review 1.  Renal osteodystrophy.

Authors:  E A González; K J Martin
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

Review 2.  Vitamin D and analogues in renal bone disease and implications for osteoporosis.

Authors:  J A Kanis; E V McCloskey; M N Beneton
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

3.  The pathophysiology of bone and joint disease.

Authors:  S L Teitelbaum; P G Bullough
Journal:  Am J Pathol       Date:  1979-07       Impact factor: 4.307

4.  Hyperparathyroidism in renal failure.

Authors: 
Journal:  Br Med J       Date:  1978-02-18

5.  Hypohyperparathyroidism: a model for renal osteodystrophy?

Authors:  B J Junor; N Edward
Journal:  Postgrad Med J       Date:  1981-06       Impact factor: 2.401

6.  Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure.

Authors:  S Lopez-Hilker; T Galceran; Y L Chan; N Rapp; K J Martin; E Slatopolsky
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

7.  Neurodiagnostic abnormalities in patients with acute renal failure.

Authors:  J D Cooper; V C Lazarowitz; A I Arieff
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

8.  Quantitative bone histology in 38 patients with advanced renal failure.

Authors:  J B Eastwood
Journal:  J Clin Pathol       Date:  1982-02       Impact factor: 3.411

9.  Abnormal skeletal response to parathyroid hormone in dogs with chronic uremia.

Authors:  K Olgaard; M Arbelaez; J Schwartz; S Klahr; E Slatopolsky
Journal:  Calcif Tissue Int       Date:  1982-07       Impact factor: 4.333

10.  Immunohistochemical study of nodular hyperplastic parathyroid glands in patients with secondary hyperparathyroidism.

Authors:  T Oka; T Yoshioka; G R Shrestha; T Koide; T Sonoda; S Hosokawa; K Onoe; M Sakurai
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.